[Adjuvant chemotherapy of intraocular malignant melanoma. Apropos of 20 cases]. 1985

M Sellami, and M Weil, and J Maral, and G Auclerc, and P Dhermy, and D Aron-Rosa, and C Jacquillat

The frequency of haematogenously propagated hepatic metastases occurring from intra-ocular melanoma led us to treat 20 patients with adjuvant chemotherapy. 19 patients starting chemotherapy during the month following enucleation and one patient, a year after enucleation. With a median follow-up of 6 years, 17 patients (80%) are disease-free. Three patients developed hepatic metastases at 24, 24 and 30 months respectively. The résults suggest that adjuvant chemotherapy is effective in preventing metastases from intra-ocular melanoma.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003606 Dacarbazine An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564) DTIC,5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide,Biocarbazine,DIC,DTIC-Dome,Decarbazine,Deticene,Dimethyl Imidazole Carboxamide,Dimethyl Triazeno Imidazole Carboxamide,ICDT,NSC-45388,Carboxamide, Dimethyl Imidazole,DTIC Dome,DTICDome,Imidazole Carboxamide, Dimethyl,NSC 45388,NSC45388
D005134 Eye Neoplasms Tumors or cancer of the EYE. Cancer of Eye,Eye Cancer,Cancer of the Eye,Neoplasms, Eye,Cancer, Eye,Cancers, Eye,Eye Cancers,Eye Neoplasm,Neoplasm, Eye
D005260 Female Females

Related Publications

M Sellami, and M Weil, and J Maral, and G Auclerc, and P Dhermy, and D Aron-Rosa, and C Jacquillat
January 2000, Revue de laryngologie - otologie - rhinologie,
M Sellami, and M Weil, and J Maral, and G Auclerc, and P Dhermy, and D Aron-Rosa, and C Jacquillat
March 1962, Archivos argentinos de dermatologia,
M Sellami, and M Weil, and J Maral, and G Auclerc, and P Dhermy, and D Aron-Rosa, and C Jacquillat
September 1987, Journal of surgical oncology,
M Sellami, and M Weil, and J Maral, and G Auclerc, and P Dhermy, and D Aron-Rosa, and C Jacquillat
February 1985, American journal of clinical oncology,
M Sellami, and M Weil, and J Maral, and G Auclerc, and P Dhermy, and D Aron-Rosa, and C Jacquillat
October 1998, Annales de chirurgie plastique et esthetique,
M Sellami, and M Weil, and J Maral, and G Auclerc, and P Dhermy, and D Aron-Rosa, and C Jacquillat
January 1978, Medecine & chirurgie digestives,
M Sellami, and M Weil, and J Maral, and G Auclerc, and P Dhermy, and D Aron-Rosa, and C Jacquillat
November 2016, Journal of the European Academy of Dermatology and Venereology : JEADV,
M Sellami, and M Weil, and J Maral, and G Auclerc, and P Dhermy, and D Aron-Rosa, and C Jacquillat
April 1978, Cancer,
M Sellami, and M Weil, and J Maral, and G Auclerc, and P Dhermy, and D Aron-Rosa, and C Jacquillat
January 1981, Folia haematologica (Leipzig, Germany : 1928),
M Sellami, and M Weil, and J Maral, and G Auclerc, and P Dhermy, and D Aron-Rosa, and C Jacquillat
January 1993, Eye (London, England),
Copied contents to your clipboard!